Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Baricitinib is an effective treatment for severe alopecia areata.

Topical human epidermal growth factor may effectively treat acne caused by cancer medication.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Fisetin in fruits and vegetables helps hair growth in mice.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Upadacitinib effectively treated severe hair loss in a child.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.